As Moderna, Pfizer and Johnson & Johnson start looking at ways to fight the new omicron variant, Central Florida research labs are preparing just in case they're needed for testing.
The potential for variants to evade current COVID-19 vaccines has scientists from Pfizer and Moderna racing to develop yet another new type of shot that many are calling a ‘super vaccine,’ which could be variant-proof.
DeLand s Accel Enters Phase 3 of Johnson & Johnson, Novavax Vaccine Trials UPDATED 4:36 PM ET Feb. 16, 2021 PUBLISHED 12:30 PM ET Feb. 16, 2021 PUBLISHED 12:30 PM EST Feb. 16, 2021
SHARE
DELAND, Fla. Accel Clinical Research in DeLand is now more than six months into coronavirus vaccine trials, deep into work on the Pfizer and Moderna products and in the early stages of trials of the Johnson & Johnson and Novavax vaccines.
Staffers are working seven days a week, vaccinating hundreds of people from various age groups and ethnicities.
What You Need To Know
Participants who got placebo in Pfizer, Moderna shots getting real vaccine
Volunteers in Johnson & Johnson trials receiving second shots
FOX 35 EXCLUSIVE: Pfizer to prioritize trial participants for COVID vaccine
Pfizer offering COVID vaccine to trial volunteers
A clinic in DeLand ran duel COVID-19 trials for both Pfizer and Moderna vaccines. Pfizer on Wednesday announced it will give the vaccine to trial participants who received a placebo during the trial.
DELAND, Fla. - Central Floridians who participated in the Pfizer COVID-19 vaccine trials and received the non-active placebo solution will be moved up the list to get the real deal.
“We should make sure that we take care of those people that were courageous and came in, upfront, early July, August and got on the trial,” said Dr. Bruce Rankin, Medical Director at Accel Clinical Research in DeLand.